ASCENT Intervention for Brain Tumor Patients
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMassachusetts General Hospital
About this trial
The goal of this study is to refine and test a psychosocial intervention called ASCENT (ACT-based Supportive intervention for patients with CENTral nervous system tumors). This intervention was developed to help patients after being diagnosed with a brain tumor. The main question this study aims to answer is whether this intervention is feasible (i.e., possible to carry out) and acceptable (i.e., considered helpful) to patients. Participants will be asked to take part in 6 coaching sessions and complete short surveys at four different time points. Some participants will be asked to share feedback via interviews.
Eligibility criteria
Qualifiers
Age ≥ 18
Massachusetts General Hospital Cancer Center Patient
Within 6 months of diagnosis of malignant primary Central Nervous System (CNS) tumor
English speaking
Disqualifiers
Inability to provide informed consent as assessed by the study team (e.g., due to severe cognitive impairment/dementia)
Moderate to severe receptive aphasia (Quick Aphasia Battery sentence comprehension subscale < 8)
Current or imminent hospice enrollment
Trial design
Treatments tested in this trial
- Psychosocial intervention
- Usual supportive care
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov